Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug effects on exercise-induced late asthmatic responses.

Y Iikura1, H Inui, T Obata

  • 1Department of Allergy and Immunology, National Children's Medical Research Centre, Tokyo, Japan.

New England and Regional Allergy Proceedings
|May 1, 1988
PubMed
Summary

This study examined how four drugs affect asthma reactions caused by exercise. Disodium cromoglycate stopped both early and late responses in ten children. Prednisolone and beclomethasone only reduced the late response in eleven and five children, respectively. Salbutamol mainly affected the early response in ten children. The researchers also looked at how these drugs influenced airway inflammation and airflow. The findings suggest that each drug works differently to modify the asthma reaction. The study highlights similarities between asthma triggered by exercise and by allergens. These results may help in choosing the best treatment for exercise-induced asthma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunosuppression in Chronic Asthma.

International archives of allergy and immunology·2021
Same author

The early history of the eosinophil.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
Same author

Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous ('idiopathic') urticaria.

The British journal of dermatology·2014
Same author

Calcitonin gene-related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
Same author

Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin.

The British journal of dermatology·2014
Same author

Immunotherapy is allergen-specific: a double-blind trial of mite or timothy extract in mite and grass dual-allergic patients.

International archives of allergy and immunology·2012

Area of Science:

  • Respiratory medicine
  • Pharmacology in asthma management
  • Exercise-induced bronchoconstriction

Background:

Exercise-induced asthma is a well-documented phenomenon. It involves two distinct phases: an immediate early response and a delayed late response. Prior research has shown that these responses are linked to airway inflammation and bronchoconstriction. However, the specific mechanisms remain unclear. No prior work had resolved how different drugs affect these dual phases. This gap motivated the current investigation into drug effects on exercise-induced asthma. It was already known that anti-inflammatory agents may influence airway responses. Yet, the comparative efficacy of various drugs in this context remained uncertain. This paper contributes by examining how specific pre-treatments alter the dual asthmatic reaction. The findings offer insights into drug-specific mechanisms of action.

Purpose Of The Study:

The study aimed to evaluate how different drugs affect the dual asthmatic reaction caused by exercise. The specific problem addressed is the variability in drug effects on early and late asthmatic responses. This uncertainty drove the decision to test four drugs separately in different groups of children. The motivation stems from the need to understand drug-specific mechanisms in asthma management. The researchers sought to determine whether these drugs could inhibit either or both phases of the reaction. The goal was to compare disodium cromoglycate, prednisolone, beclomethasone, and salbutamol. The study also aimed to assess correlations between drug effects and inflammatory markers. The findings could inform treatment strategies for exercise-induced asthma.

Keywords:
exercise-induced asthmaasthmatic response drugsFEV1 in asthmainflammatory markers in asthma

Frequently Asked Questions

The main outcome is that disodium cromoglycate inhibits both early and late asthmatic responses, while other drugs target only one phase.

Salbutamol mainly inhibits the early phase of the reaction but has limited effect on the late phase.

FEV1 was measured to assess airflow limitation and correlate it with inflammatory markers like neutrophil chemotactic activity.

Neutrophil chemotactic activity correlates with airflow limitation in disodium cromoglycate and prednisolone groups but not consistently in others.

Related Experiment Videos

Main Methods:

The study involved administering four drugs to separate groups of children with exercise-induced asthma. Each drug was given before a cycle ergometer exercise task. Disodium cromoglycate was tested on ten participants. Prednisolone was given to eleven children, and beclomethasone to five. Salbutamol was administered to ten others. The researchers monitored both early and late asthmatic responses after exercise. They measured airflow limitation using FEV1. Neutrophil chemotactic activity was also assessed. The study compared drug effects on the dual reaction phases. The data were analyzed to determine drug-specific patterns of response.

Main Results:

Disodium cromoglycate completely inhibited the dual asthmatic reaction in ten children. Prednisolone and beclomethasone suppressed only the late phase in eleven and five participants, respectively. Salbutamol mainly reduced the early phase in ten children. FEV1 changes were observed but varied across drug groups. Neutrophil chemotactic activity correlated with airflow limitation in disodium cromoglycate and prednisolone groups. However, discrepancies were noted in beclomethasone and salbutamol studies. The results suggest drug-specific mechanisms of action. The findings also indicate similarities between antigen- and exercise-induced responses.

Conclusions:

The authors propose that each drug modifies the dual asthmatic reaction through distinct mechanisms. Disodium cromoglycate inhibits both phases, while others target only one. The study shows that drug effects vary in their ability to suppress early or late responses. Correlations between FEV1 and neutrophil activity were not consistent across all drug groups. The findings suggest that inflammation plays a role in both phases of the reaction. The results imply that drug choice may depend on the specific phase to be addressed. The authors do not claim that these drugs are essential for asthma management. The study highlights the need for further research into drug-specific mechanisms.

The dual reaction includes an early and late phase, both of which are modified differently by the drugs tested in the study.

The findings suggest that each drug modifies the dual asthmatic reaction through a distinct mechanism, as shown by their differential effects on early and late responses.